SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs has informed that the Company convened its 42nd Annual General Meeting (AGM) on 30th July, 2021 and the business mentioned in the Notice was transacted and passed with requisite majority. In this regard, it enclosed the following; Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. Report of the Scrutinizer from Kaushal Doshi of Kaushal Doshi & Associates - Practicing Company Secretary dated 30th July, 2021, pursuant to Section 108 of the Companies Act, 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration), Rules 2014.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

58.55 0.39 (0.67%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×